Search results
ML Lather appointed as Chief Information Commissioner of Rajasthan | Jaipur News - Times of India
The Times of India· 1 day agoJaipur: Governor Kalraj Mishra has appointed former DGP Mohan Lal Lather as the chief information...
As Dengue Cases Up, Bengaluru Blood Banks See Surge In Platelets Requests
One India· 4 days agoDengue outbreak in bengaluru: The rising dengue cases and increasing cases of hospitalisation have...
Nephro Care shares list at 90% premium on NSE SME platform - The Economic Times
The Economic Times· 2 days agoThe IPO, which was completely a fresh equity sale of 45.84 lakh shares generated massive response...
Nephro Care India IPO subscribed nearly 716 times
YourStory· 4 days agoThe kidney care provider intends to utilise Rs 26.17 crore of the IPO proceeds for setting-up a multi-speciality healthcare facility, Vivacity Multi...
Latest News Today Live Updates July 5, 2024: Rishi Sunak's party loses UK polls 2024, YouTuber mocks...
Livemint· 1 day agoLatest News Today Live Updates: Today's news roundup to get a lowdown of global and local events and...
FPJ Impact: Govt Orders Probe Into Death Of 21 Newborn Babies At Thane's Kalwa Hospital, Congress...
Free Press Journal· 1 day agoThane: The Mahayuti government has swung into action after the FPJ front-paged on Friday the death...
Aerovate slashes workforce after failed Phase IIb trial
Clinical Trials Arena· 4 days agoMarketed by Novartis as Gleevec, imatinib is available as a generic cancer treatment. Oral imatinib...
Researchers find how physical exercise prevents nerve damage during chemotherapy - ET HealthWorld
The Economic Times· 5 days agoBasel: Damage to nerves brought on by cancer therapies frequently results in symptoms that endure a...
Will Narayana Health's mediclaim plan 'Aditi' make health insurance palatable - CNBC TV18
CNBC TV18· 2 days agoCombining the two brings synergy and quick processing with hospitals not going overboard, salivating at the prospect of squeezing more out of the patient armed with an insurance ...
Boehringer and OSE to advance cancer immunotherapy to clinics
Pharmaceutical Technology· 3 days agoIn May 2024, Boehringer expanded its collaboration with OSE, acquiring a preclinical oncology asset...